Suppr超能文献

芬兰心血管研究(FINCAVAS):对心血管疾病发病和死亡高风险患者进行特征分析。

The Finnish Cardiovascular Study (FINCAVAS): characterising patients with high risk of cardiovascular morbidity and mortality.

作者信息

Nieminen Tuomo, Lehtinen Rami, Viik Jari, Lehtimäki Terho, Niemelä Kari, Nikus Kjell, Niemi Mari, Kallio Janne, Kööbi Tiit, Turjanmaa Väinö, Kähönen Mika

机构信息

Department of Pharmacological Sciences, Medical School, University of Tampere, Finland.

出版信息

BMC Cardiovasc Disord. 2006 Mar 3;6:9. doi: 10.1186/1471-2261-6-9.

Abstract

BACKGROUND

The purpose of the Finnish Cardiovascular Study (FINCAVAS) is to construct a risk profile--using genetic, haemodynamic and electrocardiographic (ECG) markers--of individuals at high risk of cardiovascular diseases, events and deaths.

METHODS AND DESIGN

All patients scheduled for an exercise stress test at Tampere University Hospital and willing to participate have been and will be recruited between October 2001 and December 2007. The final number of participants is estimated to reach 5,000. Technically successful data on exercise tests using a bicycle ergometer have been collected of 2,212 patients (1,400 men and 812 women) by the end of 2004. In addition to repeated measurement of heart rate and blood pressure, digital high-resolution ECG at 500 Hz is recorded continuously during the entire exercise test, including the resting and recovery phases. About 20% of the patients are examined with coronary angiography. Genetic variations known or suspected to alter cardiovascular function or pathophysiology are analysed to elucidate the effects and interactions of these candidate genes, exercise and commonly used cardiovascular medications.

DISCUSSION

FINCAVAS compiles an extensive set of data on patient history, genetic variation, cardiovascular parameters, ECG markers as well as follow-up data on clinical events, hospitalisations and deaths. The data enables the development of new diagnostic and prognostic tools as well as assessments of the importance of existing markers.

摘要

背景

芬兰心血管研究(FINCAVAS)的目的是利用基因、血流动力学和心电图(ECG)标志物构建心血管疾病、事件和死亡高风险个体的风险概况。

方法与设计

2001年10月至2007年12月期间,所有计划在坦佩雷大学医院进行运动应激试验且愿意参与的患者均已被招募,并将继续招募。预计最终参与者人数将达到5000人。截至2004年底,已收集了2212例患者(1400名男性和812名女性)使用自行车测力计进行运动试验的技术成功数据。除了重复测量心率和血压外,在整个运动试验期间,包括静息和恢复阶段,还连续记录500Hz的数字高分辨率心电图。约20%的患者接受冠状动脉造影检查。分析已知或疑似改变心血管功能或病理生理学的基因变异,以阐明这些候选基因、运动和常用心血管药物的作用及相互作用。

讨论

FINCAVAS汇编了关于患者病史、基因变异、心血管参数、心电图标志物以及临床事件、住院和死亡随访数据的大量数据。这些数据有助于开发新的诊断和预后工具,并评估现有标志物的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/1413555/f9c45c98b6b6/1471-2261-6-9-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验